Investigations found that the batch number does not match AbbVie’s records, the US-based manufacturer of Botox Cosmetic
The Establishment said the product was not brought into the UAE through approved import channels.
It warned that using counterfeit medical products can be dangerous because they do not meet approved safety and quality standards. This could lead to harmful reactions, unexpected side effects or other health complications.
Healthcare providers, pharmacies and medical facilities have been urged to carefully check the authenticity of medical products before using or dispensing them.
The authority also instructed them to immediately stop using, distributing or selling any units carrying the batch number C7048C4.
Patients who have received Botox treatment and experience any unusual symptoms are advised to consult a doctor or pharmacist.
The Emirates Drug Establishment urged healthcare professionals and members of the public to remain alert and report any suspected counterfeit products.
Any information related to the sale, distribution or handling of the batch can be reported to the National Medical Products Vigilance Department.
